IPP Bureau
Syngene International posts Q4 FY25 consolidated profit at Rs. 183.3 Cr
By IPP Bureau - April 24, 2025
Syngene reported revenue growth of 11% year-on-year, and 8% sequentially crossing the Rs. 1,000 Cr in a quarter threshold for the first time
Thyrocare Technologies Q4 FY25 consolidated PAT up at Rs. 21.70 Cr
By IPP Bureau - April 24, 2025
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
Akums and Tamil Nadu Agricultural University announce partnership for pharmaceutical innovation
By IPP Bureau - April 24, 2025
Akums and TNAU will collaborate to strengthen research through shared expertise and innovative agricultural solutions, to foster innovation in formulation development
Pfizer advances vision for future of cancer care at ASCO 2025 Annual Meeting
By IPP Bureau - April 24, 2025
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
Sun Pharma and Moebius Medical announce dual publications on MM-II’s phase 2b clinical trial results in Osteoarthritis and Cartilage
By IPP Bureau - April 24, 2025
Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA modelsfeatured in two peer-reviewed articles
Lupin receives USFDA approval for Tolvaptan Tablets
By IPP Bureau - April 24, 2025
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Lupin Diagnostics achieves NABL accreditation for all greenfield labs
By IPP Bureau - April 24, 2025
The 27 greenfield labs across the country ensure timely and accurate reporting
Wanbury to implement the SAP S/4 HANA private cloud platform
By IPP Bureau - April 24, 2025
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
Caplin Steriles gets USFDA approval for Phytonadione Injectable Emulsion
By IPP Bureau - April 24, 2025
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
Eugia Pharma receives USFDA approval for Dasatinib Tablets
By IPP Bureau - April 24, 2025
Dasatinib Tablets is indicated for the treatment of (i) newly diagnosed adults with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia
Remedium unveils Rights Issue post Rs. 182.7 crore UK deal to drive global expansion
By IPP Bureau - April 24, 2025
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
DHL Express and Sai Life Sciences sign GoGreen Plus partnership to make pharma deliveries more sustainable
By IPP Bureau - April 24, 2025
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
Laurus Labs Q4 FY25 PAT up 208% to Rs. 234 Cr
By IPP Bureau - April 24, 2025
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
Nureca receives approval for new manufacturing facility
By IPP Bureau - April 23, 2025
This unit will focus on the manufacturing of health and wellness equipment
